Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.800
0.00 (0.00%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $289.93 million as of September 11, 2026. Its market cap has decreased by -23.32% in one year.
Market Cap
289.93M
Enterprise Value
-23.63M
1-Year Change
-23.32%
Ranking
Category
Stock Price
$3.80
ChartMarket Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has decreased from $301.64M to $289.93M, a decrease of -3.88%. That is a compound annual growth rate of -0.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 289.93M | -61.14% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 304.73M |
| InflaRx | 302.10M |
| Lyell Immunopharma | 298.96M |
| Immuneering | 295.67M |
| Sutro Biopharma | 295.64M |
| Clinuvel Pharmaceuticals | 290.76M |
| Fate Therapeutics | 279.18M |
| YD Bio | 274.25M |